1. Baines MJ: The pathophysiology and management of malignant intestinal obstruction. In Oxford Textbook of Palliative Medicine. Edited by Doyle D, Hanks GWC, MacDonald N. Oxford: Oxford University Press; 1998:526–534.
2. Storey PS: Obstruction of the GI tract. Am J Hospice Palliat Care 1991, 8:5.
3. Mystakidou K, Tsilika E, Kalaidopoulou O, Papadimitriou L: Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled clinical trial. Anticancer Res 2002, 22:1187–1192.
4. Mercadante S, Ripamonti C, Casuccio A, et al.:Comparison of ocreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 2000, 8:188–191.
5. Mangigi G, Aletti G, Frigerio L, et al.: Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. Int J Gynecol Cancer 2005, 15:830–835.